Poltreg (WAR:PTG) Common Stock: zł0.47 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:PTG Poltreg SA WAR:PTG
42 GF Score
Price zł23.50
GF Value zł14.20
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Poltreg Common Stock?

Poltreg WAR:PTG -2.89% 42 Common Stock is zł0.47 Mil as of Mar. 2026. GuruFocus rates WAR:PTG with a GF Score™ of 42/100 and a GF Value™ of zł14.20 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Poltreg's quarterly common stock stayed the same from Sep. 2025 (zł0.47 Mil) to Dec. 2025 (zł0.47 Mil) and stayed the same from Dec. 2025 (zł0.47 Mil) to Mar. 2026 (zł0.47 Mil).

Poltreg's annual common stock stayed the same from Dec. 2023 (zł0.47 Mil) to Dec. 2024 (zł0.47 Mil) and stayed the same from Dec. 2024 (zł0.47 Mil) to Dec. 2025 (zł0.47 Mil).

Poltreg Common Stock Historical Data

* Premium members only.

The historical data trend for Poltreg's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poltreg Common Stock Chart

Poltreg Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 0.47 0.47 0.47 0.47 0.47

Poltreg Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.47 0.47 0.47 0.47
WAR:PTG
42GF Score
Poltreg SA WAR:PTG
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Poltreg Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of zł0.47 Mil mean?
Poltreg (WAR:PTG) has a Common Stock of zł0.47 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Poltreg and its competitors.
Is Poltreg's Common Stock too high?
Poltreg's current Common Stock is zł0.47 Mil. Overall, Poltreg has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Poltreg's Common Stock compare to VRTX and REGN?
Poltreg's Common Stock of zł0.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Poltreg and its competitors. Poltreg's current Common Stock is zł0.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poltreg stock overvalued right now?
Based on GuruFocus' analysis, Poltreg (WAR:PTG) is currently considered Significantly Overvalued. The stock's GF Value™ is zł14.20, compared to a current price of zł23.50 — trading 65.5% above its estimated fair value. The current Common Stock is zł0.47 Mil. Poltreg's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Poltreg (WAR:PTG), the current Common Stock is zł0.47 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Poltreg (WAR:PTG) Overvalued in 2026?

Based on GuruFocus' analysis, Poltreg stock appears to be overvalued. The current stock price of zł23.50 is trading 65.5% above its estimated GF Value™ of zł14.20. GuruFocus considers Poltreg to be Significantly Overvalued.

Key valuation signals for WAR:PTG:

  • Common Stock: zł0.47 Mil
  • GF Value™: zł14.20 vs. price of zł23.50 (65.5% above fair value)
  • GF Score™: 42/100 with 3 warning signs

No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Poltreg Business Description

Address ul.Botaniczna 20, Gdansk, POL, 80-298
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
42GF Score

Get the complete analysis for WAR:PTG

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł23.50
Price
zł14.20
GF Value